SlideShare a Scribd company logo
1 of 18
CASE PRESENTATION ON LIVER
FAILURE
CICILIYA VJ
KH.PH.U4BPH13013
8th SEMESTER B.PHARM
AMRITA SCHOOL OF PHARMACY
DEMOGRAPHIC DETAILS
 MRD NO : 1775191
 PATIENT NAME : Mr. BIJU B
 AGE :44 Y
 SEX : MALE
 SPECIALITY : GASTROENTEROLOGY
 DATE OF ADMISSION : 03/12/2016
 DATE OF DISCHGARGE : 23/01/2017
SUBJECTIVE DATA
 REASON OF ADMISSION : 44 yr old Mr Biju has acute on
chronic liver failure(ACLF) , severe alcoholic hepatitis . He
developed LRTI / Pulmonary edema during the hospital stay
.Treated with antibiotics, nebulization. Later developed ascites .
OGD scopy showed e/o esophageal varices .
 HISTORY: h/o chronic ethanol intake presented with c/o
progressive jaundice since 3 weeks to have worsening jaundice,
renal failure and he came here for further management
 PERSONAL HISTORY : normal sleep , and appetite ,
bladder and bowel habits
 FAMILY HISTORTY : nil
 ALLERGIES : nil
OBJECTIVE DATA
 VITALS
 PR: 76 beats /min
 BP: 130/70mmHg
 RR: 16 breaths/min
LAB INVESTIGATIONS
HAEMOGRAM
DATE Hb;g/d
l(12.1-
15.1)
PCV :
% (45)
PlT
:ku/ml(15
0-450)
TC:45-
110)
DC:%(
40-80)
L:%(20-
40)
E :%(1-
6)
13/12 8.41 24.3 63.6 15.5 76 12.9 1.65
14/12 9.3 26.2 66 13.97 78.5 12.6 3.8
15/12 8.6 24.1 59 12.86 77.2 13.3 4.4
16/12 8.5 24.1 60 11.62 77.1 14.1 2.9
17/12 8.31 25 63.8 14.5 74.2 10.6 3.11
18/12/ 8.32 24.9 58.7 14.1 69.8 12.7 5.37
20/12 8.5 25.1 46 10.3 73.9 12.7 3.5
21/12 8.5 24.8 46 10.3 71.4 13.3 4.3
22/12 7.8 23 43 7.26 68.4 20.5 5.5
23/12 8.1 23.8 43 7.2 68.4 20.5 5.5
24/12 7.2 20.5 50 6.52 71.2 18.1 5.2
25/12 8.1 24 34 6.93 68.8 17.6 8.8
26/12 8 23.1 23 7.83 67.8 19.7 5.9
27/12 7.5 22.1 31 9.57 80.2 9.4 5
28/12 7.4 21.4 22 10.4 70.9 13.6 8.3
29/12 8.3 24.2 33 10.9 71.8 14.9 6.8
30/12 8.4 24 44 10.6 66.4 15.4 4.7
31/12 8.6 24.3 56 70.7 70.7 17.5 4.7
1/01 9.1 26.7 51 11.8 67.7 18.9 5.8
2/01 9.3 26.1 140 12.8 72.3 15.5 5.4
3/01 8.9 27 75 11.3 58.6 24 3.8
4/01 8.4 24.4 80 11.71 69.6 19.6 4.1
5/01 8.8 25.3 85 11.8 67.4 20 4.9
6/01 8.6 24.2 80 10 66.9 20 4.1
LIVER FUNCTION TEST
DATE T:Bilir
ubin(.
3-1.9)
D:bilir
ubin
SGOT:I
U/L
SGPT:I
U/L(5-
40)
ALP
(44-
114)
T:protein(
gm
/dL)
S:al
b
S:glob(g
/dL)
15/12 - - 130.8 40.3 - - - -
17/12 39.6 24.7 165 51.5 69.5 6.43 4 2.4
20/12 32.3 21.6 165.3 60 71.2 6.5 3.85 2.7
24/12 21.7 8.64 216.1 73.9 62.7 7.01 4.28 2.7
26/12 25.9 16 211.3 90.9 67.6 6.77 3.99 2.8
31/12 31.6 21.8 204.9 103.6 70.4 7.08 3.82 3.3
02/01 29.7 22.4 231.7 107.5 80.9 6.9 3.57 3.3
03/01 26.9 19.3 240.5 100.8 77.6 6.28 3.21 3.1
05/01 28.9 17.3 231.7 98.4 83.7 6.1 2.84 3.3
06/01 31.2 17.7 230.1 97.2 77.2 6.02 2.84 3.2
08/01 29.6 18.2 245.9 91.3 83.2 6.43 2.87 3.6
12/01 36.6 19.4 223.1 77.4 78.8 6.52 3.18 3.3
16/01 30.6 17.7 157.9 47.5 80.4 6.45 3.28 3.2
RENAL FUNCTION TEST AND SERUM
ELECTROLYTES
Date: Urea
:mg/dL7-20
CREATININE:
mg/dL.(.7-1.3)
Na+:mEq/l K+: Eq/L
12/12 - - - 3.5
13/12 150.5 4.0 137.1 3.5
14/12 128.8 2.95 137 3.2
15/12 163.5 2.93 138.8 2.7
16/12 154.5 2.87 146.8 2.7
17/12 158.1 2.51 150.2 2.7
18/12 137.3 2.13 138.9 3.4
19/12 109 1.99 140.6 3.6
20/12 122.3 2.51 139.7 3.3
21/12 133.5 2.49 139.4 3.6
22/12 136.2 2.29 142.2 3.3
23/12 112 1.96 145.5 3
24/12 95.8 1.78 145.5 3.7
25/12 74.8 1.62 148.7 2.8
26/12 59.9 1.69 147.2 3.3
27/12 57.8 2.01 144.5 3.4
28/12 73.9 2.43 145.5 3
29/12 70.2 2.3 145 2.7
30/12 71.6 2.31 146 2.7
31/12 74.4 2.24 144.5 2.5
1/1 69.2 2 143.2 2.8
2/1 71.4 2 144 2.6
3/1 75 2.2 139.3 3.4
4/1 62.7 2.2 135.3 3.9
5/1 - - 132.3 2.8
6/1 54.9 2.24 131.8 3.8
7/1 48.9 2.18 129.7 5
8/1 51.1 2.38 126.2 4.9
9/1 48.1 2.27 125.2 4
10/1 40.1 1.81 125.1 3.2
11/1 39.5 1.68 126.8 3.2
12/1 39.9 1.95 126.6 4.3
13/1 42.4 2 129.1 3.4
14/1 39.3 1.9 127.3 3.5
15/1 40.4 2 125.8 3.7
16/1 46.7 2.2 125.6 3.8
17/1 57.3 2.2 125.8 3.8
18/1 52.3 1.88 124.6 3.6
ASSESSMENT
DIAGNOSIS:
• Acute on chronic liver failure
• Severe Alcoholic Hepatitis Lower respiratory tract
infection with respiratory failure (S/p Intubation)
• Acute kidney injury (non oliguric)
• Ascites
 DISEASE DESCRIPTION :
• LIVER FAILURE :large part of liver become damaged , life
threatening condition. Major cause – hepatitis ; inflammation of the
liver which results in damage to hepatocytes with subsequent cell
death
• Symptoms- nausea, loss of appetite, fatigue
• Liver transplantation is common procedure
 GOALS OF THERAPY
• Treat hepatitis by getting vaccination
• Reduce the symptoms
PLAN
PLAN OF DISCHARGE : Review with gastro medicine
OPD after 1 week with CBC/CRP/LFT/INR/ISE/RBS
reports
DISCHARGE MEDICATION
MEDICATION FREQUEN
CY
DOSE ROUTE
T.TAXIM O 200mg 1-0-1* 1 week p/o
T.PAN 40mg 1-0-1 ‘’ ‘’
T.UDILIV 300mg 1-0-1 ‘’ ‘’
T.RIFAGUT 400mg 1-0-1 ‘’ ‘’
T.NORFLOX 400mg 1-0-0 ‘’ ‘’
T.NEUROBION FORTE 1gm 1-0-0 ‘’ ‘’
T.FLOVITE 5mg 1-0-0 ‘’ ‘’
T.CILACAR 10mg 1-0-1 ‘’ ‘’
T.HEPTRAL 10mg 1-0-1 ‘’ ‘’
T.EVION 400mg 1-0-0 ‘’ ‘’
INJ.HUMAN ACTRAPID 6-6-6 units s.c
HEPATOPROTEIN POWDER 2tsp TID syp p/o
MUCOLITE 10ml BD/SOS*2 ‘’ ‘’
 PATIENT COUNSELLING
o Avoid alcohol when you are taking medication
o Practice proper hygiene
o Eat proper diet from all of the food groups
o Don’t share any personal toiletry items
o Don’t handle any blood or blood products
o salt restricted diet , 3 egg white per day
o diabetic diet, 100 gm vegetable protein per day
THANK YOU..........

More Related Content

What's hot

Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionCase on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Vineetha Menon
 
Jasleen morning report 1
Jasleen morning report 1Jasleen morning report 1
Jasleen morning report 1
jasleenk06
 
cervical canal stenosis with hypothyroidism
cervical canal stenosis with hypothyroidismcervical canal stenosis with hypothyroidism
cervical canal stenosis with hypothyroidism
Dr B Naga Raju
 

What's hot (20)

CASE PRESENTATION OF LIVER CIRRHOSIS PPT by MADHUKAR THAGNAR
CASE PRESENTATION OF LIVER CIRRHOSIS PPT by MADHUKAR THAGNAR CASE PRESENTATION OF LIVER CIRRHOSIS PPT by MADHUKAR THAGNAR
CASE PRESENTATION OF LIVER CIRRHOSIS PPT by MADHUKAR THAGNAR
 
Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!
 
A case study on advanced alzheimers disease
A case study on advanced alzheimers diseaseA case study on advanced alzheimers disease
A case study on advanced alzheimers disease
 
A case presentation on cystitis
A case presentation on cystitisA case presentation on cystitis
A case presentation on cystitis
 
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionCase on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
 
11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease
 
viral hepatitis
viral hepatitis viral hepatitis
viral hepatitis
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
 
Jasleen morning report 1
Jasleen morning report 1Jasleen morning report 1
Jasleen morning report 1
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
 
Diabetes
DiabetesDiabetes
Diabetes
 
Stroke
StrokeStroke
Stroke
 
Clinical case study of Alcoholic Liver Disease by Rajendra Keshkar
Clinical case study of  Alcoholic Liver Disease by Rajendra Keshkar Clinical case study of  Alcoholic Liver Disease by Rajendra Keshkar
Clinical case study of Alcoholic Liver Disease by Rajendra Keshkar
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
 
a case study on COPD with hypertension
a case study on COPD with hypertension a case study on COPD with hypertension
a case study on COPD with hypertension
 
cervical canal stenosis with hypothyroidism
cervical canal stenosis with hypothyroidismcervical canal stenosis with hypothyroidism
cervical canal stenosis with hypothyroidism
 
10. a case study on ccf with htn
10. a case study on ccf with htn10. a case study on ccf with htn
10. a case study on ccf with htn
 
Bronchiolitis | Case Study
Bronchiolitis | Case StudyBronchiolitis | Case Study
Bronchiolitis | Case Study
 
A CASE PRESENTATION ON ALCOHOLIC LIVER DISEASE
A CASE PRESENTATION ON ALCOHOLIC LIVER DISEASEA CASE PRESENTATION ON ALCOHOLIC LIVER DISEASE
A CASE PRESENTATION ON ALCOHOLIC LIVER DISEASE
 
a case study on alcohol withdrawal syndrome
a case study on alcohol withdrawal syndrome a case study on alcohol withdrawal syndrome
a case study on alcohol withdrawal syndrome
 

Similar to case presentation on liver failure

Sabari krishnan final clinical meet 2 copy
Sabari krishnan final clinical meet 2 copySabari krishnan final clinical meet 2 copy
Sabari krishnan final clinical meet 2 copy
pgimer chandigarh
 
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
Bindu238662
 
Improving the Response to Acute Deterioration in COVID-19 and Beyond
Improving the Response to Acute Deterioration in COVID-19 and BeyondImproving the Response to Acute Deterioration in COVID-19 and Beyond
Improving the Response to Acute Deterioration in COVID-19 and Beyond
Health Catalyst
 
Date PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docxDate PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docx
edwardmarivel
 
19 Shoeb Bin Islam Acute Renal Failure
19 Shoeb Bin Islam   Acute Renal Failure19 Shoeb Bin Islam   Acute Renal Failure
19 Shoeb Bin Islam Acute Renal Failure
Dang Thanh Tuan
 
Galactosemia case presentation
Galactosemia case presentationGalactosemia case presentation
Galactosemia case presentation
Sanjeev Kumar
 
Inpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle CriscoInpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle Crisco
Kyle Crisco
 

Similar to case presentation on liver failure (20)

Sabari krishnan final clinical meet 2 copy
Sabari krishnan final clinical meet 2 copySabari krishnan final clinical meet 2 copy
Sabari krishnan final clinical meet 2 copy
 
A Case Study: Astrocytoma
A Case Study: AstrocytomaA Case Study: Astrocytoma
A Case Study: Astrocytoma
 
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
 
SCRUB.pptx
SCRUB.pptxSCRUB.pptx
SCRUB.pptx
 
Improving the Response to Acute Deterioration in COVID-19 and Beyond
Improving the Response to Acute Deterioration in COVID-19 and BeyondImproving the Response to Acute Deterioration in COVID-19 and Beyond
Improving the Response to Acute Deterioration in COVID-19 and Beyond
 
Acute pancreatitis by dr zulakha
Acute pancreatitis by dr zulakhaAcute pancreatitis by dr zulakha
Acute pancreatitis by dr zulakha
 
Date PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docxDate PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docx
 
Case Presentation ,,Mubarek (2).pptx
Case Presentation ,,Mubarek (2).pptxCase Presentation ,,Mubarek (2).pptx
Case Presentation ,,Mubarek (2).pptx
 
19 Shoeb Bin Islam Acute Renal Failure
19 Shoeb Bin Islam   Acute Renal Failure19 Shoeb Bin Islam   Acute Renal Failure
19 Shoeb Bin Islam Acute Renal Failure
 
Making cardiovascular risk reduction happen in primary care final diabetes uk
Making cardiovascular risk reduction happen in primary care final   diabetes ukMaking cardiovascular risk reduction happen in primary care final   diabetes uk
Making cardiovascular risk reduction happen in primary care final diabetes uk
 
Galactosemia case presentation
Galactosemia case presentationGalactosemia case presentation
Galactosemia case presentation
 
Sub dural hematoma
Sub dural hematomaSub dural hematoma
Sub dural hematoma
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
 
Inpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle CriscoInpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle Crisco
 
a case of abdominal aorta aneurysm-- AAA
a case of abdominal aorta aneurysm-- AAAa case of abdominal aorta aneurysm-- AAA
a case of abdominal aorta aneurysm-- AAA
 
Case Presentation: Pancreatic Clinical Chemistry Abnormalities
Case Presentation: Pancreatic Clinical Chemistry AbnormalitiesCase Presentation: Pancreatic Clinical Chemistry Abnormalities
Case Presentation: Pancreatic Clinical Chemistry Abnormalities
 
MPGN case presentation
MPGN case presentationMPGN case presentation
MPGN case presentation
 
Sepsis with Hemodyalisis
Sepsis with HemodyalisisSepsis with Hemodyalisis
Sepsis with Hemodyalisis
 
Cbp on vt (1)
Cbp on vt (1)Cbp on vt (1)
Cbp on vt (1)
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with Hypertension
 

Recently uploaded

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 

Recently uploaded (20)

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 

case presentation on liver failure

  • 1. CASE PRESENTATION ON LIVER FAILURE CICILIYA VJ KH.PH.U4BPH13013 8th SEMESTER B.PHARM AMRITA SCHOOL OF PHARMACY
  • 2. DEMOGRAPHIC DETAILS  MRD NO : 1775191  PATIENT NAME : Mr. BIJU B  AGE :44 Y  SEX : MALE  SPECIALITY : GASTROENTEROLOGY  DATE OF ADMISSION : 03/12/2016  DATE OF DISCHGARGE : 23/01/2017
  • 3. SUBJECTIVE DATA  REASON OF ADMISSION : 44 yr old Mr Biju has acute on chronic liver failure(ACLF) , severe alcoholic hepatitis . He developed LRTI / Pulmonary edema during the hospital stay .Treated with antibiotics, nebulization. Later developed ascites . OGD scopy showed e/o esophageal varices .  HISTORY: h/o chronic ethanol intake presented with c/o progressive jaundice since 3 weeks to have worsening jaundice, renal failure and he came here for further management
  • 4.  PERSONAL HISTORY : normal sleep , and appetite , bladder and bowel habits  FAMILY HISTORTY : nil  ALLERGIES : nil
  • 5. OBJECTIVE DATA  VITALS  PR: 76 beats /min  BP: 130/70mmHg  RR: 16 breaths/min
  • 7. HAEMOGRAM DATE Hb;g/d l(12.1- 15.1) PCV : % (45) PlT :ku/ml(15 0-450) TC:45- 110) DC:%( 40-80) L:%(20- 40) E :%(1- 6) 13/12 8.41 24.3 63.6 15.5 76 12.9 1.65 14/12 9.3 26.2 66 13.97 78.5 12.6 3.8 15/12 8.6 24.1 59 12.86 77.2 13.3 4.4 16/12 8.5 24.1 60 11.62 77.1 14.1 2.9 17/12 8.31 25 63.8 14.5 74.2 10.6 3.11 18/12/ 8.32 24.9 58.7 14.1 69.8 12.7 5.37 20/12 8.5 25.1 46 10.3 73.9 12.7 3.5 21/12 8.5 24.8 46 10.3 71.4 13.3 4.3 22/12 7.8 23 43 7.26 68.4 20.5 5.5 23/12 8.1 23.8 43 7.2 68.4 20.5 5.5
  • 8. 24/12 7.2 20.5 50 6.52 71.2 18.1 5.2 25/12 8.1 24 34 6.93 68.8 17.6 8.8 26/12 8 23.1 23 7.83 67.8 19.7 5.9 27/12 7.5 22.1 31 9.57 80.2 9.4 5 28/12 7.4 21.4 22 10.4 70.9 13.6 8.3 29/12 8.3 24.2 33 10.9 71.8 14.9 6.8 30/12 8.4 24 44 10.6 66.4 15.4 4.7 31/12 8.6 24.3 56 70.7 70.7 17.5 4.7 1/01 9.1 26.7 51 11.8 67.7 18.9 5.8 2/01 9.3 26.1 140 12.8 72.3 15.5 5.4 3/01 8.9 27 75 11.3 58.6 24 3.8 4/01 8.4 24.4 80 11.71 69.6 19.6 4.1 5/01 8.8 25.3 85 11.8 67.4 20 4.9 6/01 8.6 24.2 80 10 66.9 20 4.1
  • 9. LIVER FUNCTION TEST DATE T:Bilir ubin(. 3-1.9) D:bilir ubin SGOT:I U/L SGPT:I U/L(5- 40) ALP (44- 114) T:protein( gm /dL) S:al b S:glob(g /dL) 15/12 - - 130.8 40.3 - - - - 17/12 39.6 24.7 165 51.5 69.5 6.43 4 2.4 20/12 32.3 21.6 165.3 60 71.2 6.5 3.85 2.7 24/12 21.7 8.64 216.1 73.9 62.7 7.01 4.28 2.7 26/12 25.9 16 211.3 90.9 67.6 6.77 3.99 2.8 31/12 31.6 21.8 204.9 103.6 70.4 7.08 3.82 3.3 02/01 29.7 22.4 231.7 107.5 80.9 6.9 3.57 3.3 03/01 26.9 19.3 240.5 100.8 77.6 6.28 3.21 3.1 05/01 28.9 17.3 231.7 98.4 83.7 6.1 2.84 3.3 06/01 31.2 17.7 230.1 97.2 77.2 6.02 2.84 3.2 08/01 29.6 18.2 245.9 91.3 83.2 6.43 2.87 3.6 12/01 36.6 19.4 223.1 77.4 78.8 6.52 3.18 3.3 16/01 30.6 17.7 157.9 47.5 80.4 6.45 3.28 3.2
  • 10. RENAL FUNCTION TEST AND SERUM ELECTROLYTES Date: Urea :mg/dL7-20 CREATININE: mg/dL.(.7-1.3) Na+:mEq/l K+: Eq/L 12/12 - - - 3.5 13/12 150.5 4.0 137.1 3.5 14/12 128.8 2.95 137 3.2 15/12 163.5 2.93 138.8 2.7 16/12 154.5 2.87 146.8 2.7 17/12 158.1 2.51 150.2 2.7 18/12 137.3 2.13 138.9 3.4 19/12 109 1.99 140.6 3.6 20/12 122.3 2.51 139.7 3.3 21/12 133.5 2.49 139.4 3.6 22/12 136.2 2.29 142.2 3.3
  • 11. 23/12 112 1.96 145.5 3 24/12 95.8 1.78 145.5 3.7 25/12 74.8 1.62 148.7 2.8 26/12 59.9 1.69 147.2 3.3 27/12 57.8 2.01 144.5 3.4 28/12 73.9 2.43 145.5 3 29/12 70.2 2.3 145 2.7 30/12 71.6 2.31 146 2.7 31/12 74.4 2.24 144.5 2.5 1/1 69.2 2 143.2 2.8 2/1 71.4 2 144 2.6 3/1 75 2.2 139.3 3.4 4/1 62.7 2.2 135.3 3.9 5/1 - - 132.3 2.8 6/1 54.9 2.24 131.8 3.8
  • 12. 7/1 48.9 2.18 129.7 5 8/1 51.1 2.38 126.2 4.9 9/1 48.1 2.27 125.2 4 10/1 40.1 1.81 125.1 3.2 11/1 39.5 1.68 126.8 3.2 12/1 39.9 1.95 126.6 4.3 13/1 42.4 2 129.1 3.4 14/1 39.3 1.9 127.3 3.5 15/1 40.4 2 125.8 3.7 16/1 46.7 2.2 125.6 3.8 17/1 57.3 2.2 125.8 3.8 18/1 52.3 1.88 124.6 3.6
  • 13. ASSESSMENT DIAGNOSIS: • Acute on chronic liver failure • Severe Alcoholic Hepatitis Lower respiratory tract infection with respiratory failure (S/p Intubation) • Acute kidney injury (non oliguric) • Ascites
  • 14.  DISEASE DESCRIPTION : • LIVER FAILURE :large part of liver become damaged , life threatening condition. Major cause – hepatitis ; inflammation of the liver which results in damage to hepatocytes with subsequent cell death • Symptoms- nausea, loss of appetite, fatigue • Liver transplantation is common procedure
  • 15.  GOALS OF THERAPY • Treat hepatitis by getting vaccination • Reduce the symptoms PLAN PLAN OF DISCHARGE : Review with gastro medicine OPD after 1 week with CBC/CRP/LFT/INR/ISE/RBS reports
  • 16. DISCHARGE MEDICATION MEDICATION FREQUEN CY DOSE ROUTE T.TAXIM O 200mg 1-0-1* 1 week p/o T.PAN 40mg 1-0-1 ‘’ ‘’ T.UDILIV 300mg 1-0-1 ‘’ ‘’ T.RIFAGUT 400mg 1-0-1 ‘’ ‘’ T.NORFLOX 400mg 1-0-0 ‘’ ‘’ T.NEUROBION FORTE 1gm 1-0-0 ‘’ ‘’ T.FLOVITE 5mg 1-0-0 ‘’ ‘’ T.CILACAR 10mg 1-0-1 ‘’ ‘’ T.HEPTRAL 10mg 1-0-1 ‘’ ‘’ T.EVION 400mg 1-0-0 ‘’ ‘’ INJ.HUMAN ACTRAPID 6-6-6 units s.c HEPATOPROTEIN POWDER 2tsp TID syp p/o MUCOLITE 10ml BD/SOS*2 ‘’ ‘’
  • 17.  PATIENT COUNSELLING o Avoid alcohol when you are taking medication o Practice proper hygiene o Eat proper diet from all of the food groups o Don’t share any personal toiletry items o Don’t handle any blood or blood products o salt restricted diet , 3 egg white per day o diabetic diet, 100 gm vegetable protein per day